N E W S B Y T E S
Dr . K Anand Kumar , Managing Director of IIL , highlighted the significance of this development in the ongoing fight against COVID-19 , aiming to increase vaccination rates through non-invasive methods . Dr . Priyabrata Pattnaik , Deputy Managing Director , emphasized the success of industry-academia collaboration in bringing this innovative solution to the public .
Eyestem completes first set of patient injections for Dry AMD therapy
Eyestem Research , an Indian cell therapy company , has completed the first set of three patient injections for its RPE suspension therapy , Eyecyte- RPE™ , targeting Dry age-related macular degeneration ( AMD ). Dry AMD is a leading cause of blindness globally , affecting around 196 million people . Eyecyte-RPE™ , a patented suspension of retinal pigment epithelium cells , aims to replace damaged retinal cells caused by Dry AMD ' s geographic atrophy . This first-in-human trial , led by Chief Medical Officer Dr . Rajani Battu , will involve 36 patients across three leading ophthalmology centers in India .
Retinal surgeons , including Dr . Rajpal Vohra ( AIIMS , Delhi ), expressed optimism about the potential of this groundbreaking treatment , while investor Dr . Ramesh Byrapaneni hailed the achievement as a defining moment for India ’ s biotechnology sector .
Eyestem ' s preclinical studies across labs in India , Singapore , and the U . S . showed promising results , without any major safety concerns , marking a significant step forward in treating Dry AMD .
Karnataka unveils Biotechnology Policy 2024-2029
On September 6 , 2024 , Priyank Kharge , Karnataka ’ s IT and Biotechnology Minister , launched the Karnataka Biotechnology Policy 2024-2029 , targeting a $ 100 billion biotech industry market by 2030 .
The policy focuses on " Focused transformation through impactful implementation " and aims to boost biotech education , streamline regulations ,
10
BioVoiceNews | October 2024